Guopan Yu

机构：Jinan University, Second Affiliated Hospital of Guangzhou Medical University, Key Laboratory of Guangdong Province, Nanfang Hospital, Guangdong Provincial People's Hospital, Southern Medical University, Guangzhou Medical University · ORCID：0000-0002-5732-0318

发表论文 142 篇 · 总被引 1388 次 · h-index 20

代表论文

• Targeting ceramide transfer protein sensitizes AML to FLT3 inhibitors via a GRP78-ATF6-CHOP axis (2025 · Nature Communications · 被引 17)
• Single-cell profiling reveals reprogrammed hierarchy and disrupted immune-stromal ecosystem in TP53-mutated AML (2026 · Experimental Hematology and Oncology · 被引 3)
• Decitabine combined with reduced-intensity conditioning for older patients with acute myeloid leukemia in composite complete remission undergoing allogeneic hematopoietic stem cell transplantation: a multicenter, single-arm, phase 2 trial (2025 · The Lancet Regional Health - Western Pacific · 被引 3)
• Venetoclax plus azacitidine with or without homoharringtonine followed by allogeneic haematopoietic cell transplantation in patients with relapsed/refractory acute myeloid leukaemia: A multicentre cohort study (2025 · British Journal of Haematology · 被引 3)
• Targeting UGCG sensitizes AML cells to venetoclax through RAB32-mediated endoplasmic reticulum-mitochondria communication (2026 · Cell Reports · 被引 1)
• 151P: Real-world adjuvant treatment patterns in Chinese patients with resected stages I to III EGFR-mutated NSCLC: A multicenter observational study (ADDRESS, CATO-2001) (2025 · Journal of Thoracic Oncology · 被引 1)